BRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting Measures

Reuters12-11

Dec 11 (Reuters) - Prophase Labs PRPH.O:

PROPHASE LABS: SECURES GLOBAL PRIVATE EQUITY BACKING, NEARS MAJOR LOZENGE DEAL, PLANS SIGNIFICANT COST-CUTTING MEASURES
PROPHASE LABS: JAY SCHWARTZ WILL ASSIST CO IN PURSUING STRATEGIC ALTERNATIVES INCLUDING A POTENTIAL SALE OF PHARMALOZ
PROPHASE LABS: FINALIZING COST-SAVING MEASURES TARGETING NON-CORE OPERATIONS THAT WILL REDUCE OPERATING EXPENSES BY AT LEAST $6 MILLION/YEAR

Source text: ID:nGNX9zCrNg

Further company coverage: PRPH.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2490485205?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-11 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490485205","market":"us","top_or_hot":-1,"title":"BRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting Measures","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting Measures</title></head><body><p><span>Dec 11 (Reuters)</span><span> - </span>Prophase Labs <span>PRPH.O</span>:</p><ul><li><p>PROPHASE LABS: SECURES GLOBAL PRIVATE EQUITY BACKING, NEARS MAJOR LOZENGE DEAL, PLANS SIGNIFICANT COST-CUTTING MEASURES</p></li><li><p>PROPHASE LABS:  JAY SCHWARTZ WILL ASSIST CO IN PURSUING STRATEGIC ALTERNATIVES INCLUDING A POTENTIAL SALE OF PHARMALOZ</p></li><li><p>PROPHASE LABS:  FINALIZING COST-SAVING MEASURES TARGETING NON-CORE OPERATIONS THAT WILL REDUCE OPERATING EXPENSES BY AT LEAST $6 MILLION/YEAR</p></li></ul><p>Source text: <span>ID:nGNX9zCrNg</span></p><p>Further company coverage: <span>PRPH.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting Measures</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting Measures\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-11 21:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0QK:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting MeasuresDec 11 (Reuters) - Prophase Labs PRPH.O:PROPHASE LABS: SECURES GLOBAL ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0QK:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRPH","symbol_name":"ProPhase Labs","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0QK:1","article_id":"2490485205","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490485205","pubTimestamp":1733924446,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting MeasuresDec 11 (Reuters) - Prophase Labs PRPH.O:PROPHASE LABS: SECURES GLOBAL PRIVAT","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PRPH":"ProPhase Labs","BK4007":"制药"},"translate_title":"简介-Prophase Labs获得全球私募股权支持，接近重大锭剂交易，计划采取重大成本削减措施","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRPH":0.9},"content_text":"BRIEF-Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting MeasuresDec 11 (Reuters) - Prophase Labs PRPH.O:PROPHASE LABS: SECURES GLOBAL PRIVATE EQUITY BACKING, NEARS MAJOR LOZENGE DEAL, PLANS SIGNIFICANT COST-CUTTING MEASURESPROPHASE LABS:  JAY SCHWARTZ WILL ASSIST CO IN PURSUING STRATEGIC ALTERNATIVES INCLUDING A POTENTIAL SALE OF PHARMALOZPROPHASE LABS:  FINALIZING COST-SAVING MEASURES TARGETING NON-CORE OPERATIONS THAT WILL REDUCE OPERATING EXPENSES BY AT LEAST $6 MILLION/YEARSource text: ID:nGNX9zCrNgFurther company coverage: PRPH.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,event","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490485205"}